repaglinide


Also found in: Medical, Wikipedia.

re·pag·li·nide

 (rĭ-păg′lə-nīd′)
n.
An oral hypoglycemic drug, C27H36N2O4, that stimulates the release of insulin from the pancreas and is used to treat type 2 diabetes.
[re(lease) + pa(ncreas) + -glinide, antidiabetic drug suff. (shortening of -glitinide, from (me)gli(ti)nide, compound class to which it belongs).]
Translations

repaglinide

n repaglinida
Mentioned in ?
References in periodicals archive ?
Repaglinide is more efficient than glimepiride on insulin secretion and post-prandial glucose excursions in patients with type 2 diabetes.
The importance and treatment of postprandial hyperglycemia
The medication is said to be the first and only fixed-dose combination of the short-acting secretagogue repaglinide and insulin sensitizer metformin HCl for the treatment of type 2 diabetes in the United States.
Marketing gets under way for type 2 diabetes combo drug
These agents include the [alpha]-glucosidase inhibitors acarbose and miglitol, the amylin analog pramlintide, the dipeptidyl peptidase-4 inhibitor sitagliptin phosphate, the glinides nateglinide and repaglinide, the glucagon-like peptide-1 derivative exenatide, and rapid-acting, bipbasic, and inhaled insulins.
Postmeal glucose levels critical in all diabetes patients: evidence prompts international guidelines
He has type 2 diabetes and takes metformin and repaglinide, but his blood pressure is normal.
Liver disease: early signs you may be missing: maximizing your care starts with zeroing in on lab values you may be overlooking and taking advantage of algorithms that can help detect fibrosis
Among the many important topics included in this program, Triplitt has conveniently organized and defined the medications that are used to treat type 2 diabetes into two major categories--those that substantially lower fasting glucose (including metformin, TZDs, sulfonylureas, Repaglinide and basal insulins) and those that substantially lower postprandial glucose levels (including Exenatide, Sitagliptin, Nateglinide, alpha-glucose inhibitors, prandial insulins and Pramlinitide).
The complexities of type 2 diabetes
Hypoglycemic episodes occurred more frequently with second-generation sulfonylureas and repaglinide than with metformin or thiazolidinediones, although there was wide variation in the risk levels reported from the different clinical trials.
Older type 2 drugs are as effective as newer ones
The patients, aged between 33 and 80 years, had been diagnosed with type 2 diabetes for at least 1 year and had been using a combination of two oral antidiabetic agents (sulfonylurea or repaglinide plus thiazolidinedione or metformin) for at least 2 months.
Inhaled insulin performs well in type 2 diabetes: Hb[A.sub.1c] levels lower than with oral agents
Tenders are invited for Tablet/Capsule Repaglinide 1Mg
Tablet/capsule Repaglinide 1mg
d) Repaglinide is more effective at lowering A1C than nateglinide.
Initiating and intensifying therapy in type 2 diabetes: managing the progressive nature of the disease

Dictionary browser ?
Full browser ?